XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets:    
Cash and due from banks $ 49,705 $ 57,032
Cash at Federal Reserve and other banks 985,978 711,389
Cash and cash equivalents 1,035,683 768,421
Investment securities:    
Marketable equity securities 2,801 2,938
Available for sale debt securities, net of allowance for credit losses of $— 2,362,907 2,207,938
Held to maturity debt securities, net of allowance for credit losses of $— 186,748 199,759
Restricted equity securities 17,250 17,250
Loans held for sale 1,030 3,466
Loans 5,851,975 4,916,624
Allowance for credit losses (96,049) (85,376)
Total loans, net 5,755,926 4,831,248
Premises and equipment, net 73,692 78,687
Cash value of life insurance 132,104 117,857
Accrued interest receivable 22,769 19,292
Goodwill 307,942 220,872
Other intangible assets, net 21,776 12,369
Operating leases, right-of-use 28,404 25,665
Other assets 169,296 109,025
Total assets 10,118,328 8,614,787
Deposits:    
Noninterest-bearing demand 3,583,269 2,979,882
Interest-bearing 5,131,208 4,387,277
Total deposits 8,714,477 7,367,159
Accrued interest payable 653 928
Operating lease liability 30,500 26,280
Other liabilities 126,348 112,070
Other borrowings 36,184 50,087
Junior subordinated debt 100,984 58,079
Total liabilities 9,009,146 7,614,603
Commitments and contingencies (Note 9)
Shareholders’ equity:    
Preferred stock, no par value: 1,000,000 shares authorized, zero issued and outstanding at March 31, 2022 and December 31, 2021 0 0
Common stock, no par value: 50,000,000 shares authorized; 33,837,935 and 29,730,424 issued and outstanding at March 31, 2022 and December 31, 2021, respectively 706,672 532,244
Retained earnings 479,868 466,959
Accumulated other comprehensive (loss) income, net of tax (77,358) 981
Total shareholders’ equity 1,109,182 1,000,184
Total liabilities and shareholders’ equity $ 10,118,328 $ 8,614,787